Skip to main content
. 2021 Sep 21;10(9):1222. doi: 10.3390/pathogens10091222

Figure 3.

Figure 3

(A) Continent-wise and (B) clade-wise analysis based on COVID-19 patients’ gender for both period I (March 2020–February 2021) and period II (March 2021–first week of April 2021).